JCV-DNA testing during natalizumab treatment is complementary to anti-JCV antibodies for PML risk stratification
MULTIPLE SCLEROSIS JOURNAL(2011)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined